Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of domestic versus imported lenalidomide capsules in multiple myeloma
ChiCTR-TTRCC-14004670Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lenalidomide in multiple myeloma (MM) (2 arms), sponsored by West China Hospital of Sichuan University. Started Jan 2014; status: recruiting.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on ChiCTR-TTRCC-14004670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TTRCC-14004670.